BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 11, 2017
View Archived Issues
Mast Therapeutics and Savara enter merger agreement
Read More
Ramot describes drug conjugates for cancer
Read More
Jiangsu Hengrui Medicine patent reports SERDs
Read More
Houston Methodist studies tilarginine acetate for triple-negative breast cancer
Read More
KemPharm's KP-511 shows promising results in phase I study
Read More
Esperion begins pivotal efficacy studies and cardiovascular outcomes study of bempedoic acid
Read More
GSK nominates second target under Adaptimmune collaboration
Read More
AdAlta reports additional preclinical data for AD-114 in lung and liver fibrosis
Read More
Allergan purchases exclusive option right to acquire Lysosomal Therapeutics
Read More
Lexicon Pharmaceuticals begins dosing in phase I trial of LX-2761
Read More
NeuroGenetic completes phase I studies for Alzheimer's candidate
Read More
Taiwan Liposome reports topline results from phase I/II study of TLC-599
Read More
First patient treated in phase I study of RG-6016 for SCLC
Read More
Bayer patents GLUT-1 inhibitors
Read More
Novartis describes SHP-2 inhibitors
Read More
Sanofi and ImmuNext to jointly develop INX-021
Read More
Actelion Pharmaceuticals reveals NOX4 inhibitors for fibrosis
Read More
Apodemus prepares and tests PI4Kbeta inhibitors
Read More
Valeant reports positive results from second phase III study of psoriasis drug
Read More
Positive phase II results presented for Debio-1450 in patients with ABSSSI
Read More
Astellas terminates agreement with UMN Pharma for influenza vaccine programs
Read More
Targeting Pol I as a novel therapeutic strategy for preventing arterial restenosis
Read More
MRTF inhibition results in marked reduction in lung metastases in RhoC-overexpressing melanoma
Read More
Bortezomib as potential new therapeutic option for patient with severe anti-NMDAR encephalitis
Read More
SBI Biotech enters agreement with Kyowa Hakko Kirin for SBI-9674
Read More
Sarepta signs agreements with Nationwide Children's Hospital for gene therapy programs
Read More
FDA approves Egalet's Arymo ER tablets
Read More
Mikeluna launched in Japan
Read More